3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Multiple Myeloma
420
Lymphoma, Large B-Cell, Diffuse
93
Leukemia, Lymphocytic, Chronic, B-Cell
88
Lymphoma, Follicular
79
Recurrence
68
Lymphoma
60
Neoplasms, Plasma Cell
57
Lymphoma, Mantle-Cell
56
Lymphoma, B-Cell, Marginal Zone
47
Lymphoma, Non-Hodgkin
46
Leukemia, Myeloid, Acute
34
Leukemia
32
Lymphoma, B-Cell
24
Neoplasms
23
Myelodysplastic Syndromes
23
Waldenstrom Macroglobulinemia
18
Hodgkin Disease
18
Smoldering Multiple Myeloma
17
Lymphoma, T-Cell, Peripheral
16
Burkitt Lymphoma
14
Hematologic Diseases
13
Lymphoma, T-Cell, Cutaneous
12
Lymphoma, T-Cell
12
Prostatic Neoplasms
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Sezary Syndrome
10
Mycosis Fungoides
10
Lymphoma, Large-Cell, Anaplastic
9
Leukemia, Myelomonocytic, Chronic
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Interventions
Cisplatin
5
Platinum
4
Cetuximab
4
1,2-diaminocyclohexaneplatinum II citrate
4
Carboplatin
3
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Immunoglobulin G
2
Gemcitabine
2
Gefitinib
2
Fluorouracil
2
Docetaxel
2
Disulfides
2
Biopsy
2
Bevacizumab
2
vandetanib
1
temsirolimus
1
linrodostat
1
ficlatuzumab
1
durvalumab
1
dl1520
1
dehydroftorafur
1
cediranib
1
atezolizumab
1
adavosertib
1
X-Rays
1
Trioxsalen
1
Specimen Handling
1
Soybean Proteins
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lymphoid Interstitial Pneumonia
×
Lenalidomide
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled